Nebraska Medicine | Fred & Pamela Buffett Cancer Center has been named to Becker’s “100 hospitals and health systems with great oncology programs.”

Becker’s recognizes cancer programs for exceptional, innovative, and patient-centered care. The institutions on the list are recognized for driving research, pioneering treatments, and conducting clinical trials. 

The Fred & Pamela Buffett Cancer Center is Nebraska's only National Cancer Institute-designated cancer center, a distinction held by a select group of cancer centers nationwide. The designation recognizes excellence in cancer research, prevention, diagnosis, and treatment.

"As Nebraska's only National Cancer Institute-designated cancer center, we are uniquely positioned to bring groundbreaking research and clinical trials to patients across our state and region,” says Joann Sweasy, PhD, director of the Fred & Pamela Buffett Cancer Center. “With researchers and clinicians working side by side, our team can quickly translate scientific discoveries into real-time patient care.”

"Being recognized by Becker’s reflects the personal, patient-centered care our teams provide every day,” says Michaela Newman, executive director of operations for Oncology Services. “From oncologists to nurses to genetic counselors, physical therapists, dietitians and many others, we work together to ensure each patient receives personalized support and treatment.”

The Becker’s editorial team selected programs based on recent recognitions and achievements. Becker’s also accepts nominations for the list.